Hims & Hers Health Misses Q3 2026 Estimates as Revenue Rises 49% to $890.4M
Revenue of $890.4M vs. $893.1M expected and adjusted EPS of -$0.14 vs. $0.06; revenue up 49% from a year earlier.
Hims & Hers Health (HIMS) missed estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $890.4 million, up 49% from a year earlier, below the $893.1 million estimate, and adjusted EPS was -$0.14 below the $0.06 estimate.
Shares fell 5.0% in after-hours trading as of 4:07 p.m. ET, to $21.79 from a $22.93 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $0.06 | -$0.14 | Miss by 349% |
| Revenue | $893.1M | $890.4M | Miss by 0.3% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▼ from $0.06 | ▲ 62% |
| Revenue | ▲ 49% | ▲ 18% |
By our calculation, revenue was $2.8 million below the estimate and adjusted EPS was $0.20 below it. The QoQ column compares with the previous quarter's revenue of $753.2 million and adjusted EPS of -$0.37. The YoY column compares with $599.0 million and $0.06 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 2 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $599.0 million, $617.8 million, $608.1 million, $753.2 million and $890.4 million.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.12 and revenue of $953.4 million next quarter, based on 7 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 49% increase to $890.4 million.
- Estimate record. Whether Hims & Hers Health returns to beating EPS estimates, which it did in 3 of its last 8 reports.
- Related coverage. See our reports on Archer Aviation, Skydance, Septerna and Harrow Health.
Sources: Results are from Hims & Hers Health's Nov. 9, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Hims & Hers Health's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Archer Aviation Q3 2026 Revenue Tops Estimates at $5.1M, but EPS Misses at -$0.35
EarningsSkydance Q3 2026 EPS Tops Estimates at $0.45, but Revenue Misses at $7.03B
EarningsSepterna Misses Q3 2026 Estimates as Revenue Falls 12% to $18.9M
EarningsHarrow Health Beats Q3 2026 Estimates as Revenue Rises 39% to $99.3M
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.